logo
Plus   Neg
Share
Email

Stock Alert: Vaxart Hits New 52-week High As COVID-19 Vaccine Selected For OWS

Shares of Vaxart Inc. (VXRT) are surging more 90 percent or $5.65 in Friday's morning trade at $11.91 after touching a new 52-week high of $14.30 earlier. The clinical-stage biotechnology company's COVID-19 vaccine candidate has been selected for the U.S. Government's Operation Warp Speed or OWS.

Vaxart said that its oral COVID-19 vaccine has been chosen to participate in a non-human primate or NHP challenge study, organized and funded by Operation Warp Speed, a new national program aiming to provide substantial quantities of safe, effective vaccine for Americans by January 2021.

The study is designed to demonstrate the efficacy of Vaxart's oral COVID-19 vaccine candidate. Vaxart said its vaccine is the only oral vaccine being evaluated and it provides an enormous logistical advantage in large vaccination campaigns as it is a room temperature-stable tablet.

The stock has traded in a range of $0.25 to $14.30 in the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
Follow RTT